Skip to main content

Advertisement

SpringerLink
Log in

Human Histology and Persistence of Various Injectable Filler Substances for Soft Tissue Augmentation

  • Published:
Aesthetic Plastic Surgery Aims and scope Submit manuscript

Abstract

An increasing number of soft tissue filler substances have been introduced to the beauty market outside the U.S. which lackexperimental and clinical data in support of their claim. Ten commercially available filler substances were examined for biocompatibility and durability: 0.1 cc of each substance was injected deep intradermally into the volar forearm of one of the authors and observed for clinical reaction and permanence. At 1, 3, 6, and 9 months the test sites were excised, histologically examined, and graded according to foreign body reactions classification. Collagen (Zyplast) was phagocytosed at 6 months and hyaluronic acid (Restylane) at 9 months. PMMA microspheres (Artecoll) had encapsulated with connective tissue, macrophages, and sporadic giant cells. Silicone oil (PMS 350) was clinically inconspicuous but dissipated into the tissue, causing a chronic foreign body reaction. Polylactic acid microspheres (New-Fill) induced a mild inflammatory response and had disappeared clinically at 4 months. Dextran microspheres (Reviderm intra) induced a pronounced foreign body reaction and had disappeared at 6 months. Polymethylacrylate particles (Dermalive) induced the lowest cellular reaction but had disappeared clinically at 6 months. Polyacrylamide (Aquamid) was well tolerated and remained palpable to a lessening degree over the entire testing period. Histologically, it dissipated more slowly and was kept in place through fine fibrous capsules. Polyvinylhydroxide microspheres suspended in acrylamide (Evolution) were well tolerated, slowly diminishing over 9 months. Calcium hydroxylapatite microspheres (Radiance FN) induced almost no foreign body reaction but were absorbed by the skin at 12 months.Host defense mechanisms react differently to the various filler materials, but all substances— resorbable or nonresorbable—appeared to be clinically and histologically safe, although all exhibit undesirable side effects. Since the mechanism of late inflammation or granuloma formation is still unknown, early histological findings are not useful in predicting possible late reactions to filler substances.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alster, T.S., West, T.B.: Human-derived and new synthetic injectable materials for soft-tissue augmentation: Current status and role in cosmetic surgery. Plast Reconstr Surg 105, 2515 (2000)

    CAS  PubMed  Google Scholar 

  2. Amard, P.: PLA (New-Fill) as management of lipoatrophy of the face. Magazin Aesthet Surg 1, 28 (2001)

    Google Scholar 

  3. Athanasiou, K.A., Niederauer, G.G., Agrawal, C.M., Landsman, A.: Applications of biodegradable lactides and glycolides in pediatry. Implant Biomater 12, 475 (1995)

    CAS  Google Scholar 

  4. Bendszus, M., Klein, R., Burger, R., et al.: Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas. Am J Neurorad 21, 255 (2000)

    CAS  Google Scholar 

  5. Bent, A.E., Foote, J., Siegel, S., Faerber, G., Chao, R., Gormley, E.A.: Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J Urol 166, 1354 (2001)

    CAS  PubMed  Google Scholar 

  6. Bergeret-Galley, C., Latouche, X., Illouz, Y.-G.: The value of new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep. Aesth Plast Surg 25, 249 (2001)

    CAS  Google Scholar 

  7. Bigata, X., Ribera, M., Bielsa, I., Ferrandiz, C.: Adverse granulomatous reaction after cosmetic dermal silicone injection. Dermatol Surg 27, 198 (2001)

    CAS  PubMed  Google Scholar 

  8. Burres, S.: Recollagenation of acne scars. Dermatol Surg 22, 364 (1996)

    CAS  PubMed  Google Scholar 

  9. Busso M: Soft tissue augmentation with Radiance FN. Aesthetic Trends & Technologies 2(3): 2003

  10. Cahill, K.V., Burns, J.A.: Volume augmentation of the anophthalmic orbit with cross-linked collagen (Zyplast). Arch Ophthalmol 107, 1684 (1989)

    CAS  PubMed  Google Scholar 

  11. Carr, A., Samaras, K., Burton, S., et al.: A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12, F51 (1998)

    CAS  PubMed  Google Scholar 

  12. Chan, R.W., Titze, I.R.: Viscosities of implantable biomaterials in vocal cord augmentation surgery. Laryngoscope 108, 725 (1998)

    CAS  PubMed  Google Scholar 

  13. Chen AL, Desai P, Adler EM, Di Cesare PE: Granulomatous inflammation after hylan g-f 20 viscosupplementation of the knee: a report of six cases. J Bone Joint Surg (Am) 84-A:1142, 2002

  14. Cheng, N.-X., Wang, Y.-L., Wang, J.-H., Zhang, X.-M., Zhong, H.: Complications of breast augmantation with injected hydrophilic polyacrylamide gel. Aesth Plast Surg 26, 375 (2002)

    Google Scholar 

  15. Cohen SR, Holmes RE (2004) Artecoll: A longlasting wrinkle augmentation material. To be published in Plast Reconstr Surg 113:

  16. DrosbeckHP, Rothstein SS, Gumaer KI, Sherer AD, Slighter RG: J Oral Maxillofac Surg 42:143, 1984

  17. Duffy, D.M.: Injectable liquid silicone: new perspectives. In: Klein, A.W. (ed.) Tissue Augmentation in Clinical Practice: Procedures and Techniques, pp. 237–267. Marcel Dekker, New York (1998)

    Google Scholar 

  18. Duffy, D.M.: The silicone conundrum: A battle of anecdotes. Dermatol Surg 28, 590 (2002)

    PubMed  Google Scholar 

  19. Duranti, F., Salti, G., Bovani, B., Calandra, M., Rosati, M.: Injectable hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 24, 1317 (1998)

    CAS  PubMed  Google Scholar 

  20. Eppley, B.L., Summerlin, D.-J., Prevel, C.D., Sadove, A.M.: Effects of positively charged biomaterial for dermal and subcutaneous augmentation. Aesth Plast Surg 18, 13 (1994)

    Google Scholar 

  21. ErsekRA, Beisang AA: Bioplastique. A new textured copolymer microparticle promises permanence of softtissue augmentation. Plast Reconstr Surg 87:693, 1991

  22. Feretis, C., Benakis, P., Dimopoulos, C., et al.: Endoscopic implantation of Plexiglas (PMMA) microspheres for the treatment of GERD. Gastrointest Endosc 53, 423 (2001)

    CAS  PubMed  Google Scholar 

  23. Filatov AV, Mirolyubov SN: Contour plasty of maxillofacial soft tissues with biocompatible polyacrylamide gel (Russian). Stomatologiia (Mosk) 77:45, 1998

  24. Flint, P.W., Corio, R.L., Cummings, C.W.: Comparison of soft tissue response in rabbits following laryngeal implantation with hydroxylapatite, silicone rubber and Teflon. Ann Oto Rhino Laryngol 106, 399 (1997)

    CAS  Google Scholar 

  25. Friedman, P.M., Mafong, E.A., Kauvar, A.N., Geronemus, R.G.: Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 28, 491 (2002)

    PubMed  Google Scholar 

  26. Garcia-Domingo, M.I., Alijotas-Reig, J., Cistero-Bahima, A., Tresserra, F., Enrique, E.: Disseminated and recurrent sarcoid-like granulomatous panniculitis due to bovine collagen injection. J Invest Allergol Clin Immunol 10, 107 (2000)

    CAS  Google Scholar 

  27. Geile, D., Zinner, I., Erbel, F., Schaefer, M., Osterholzer, G.: Diagnosis and non-surgical treatment of faecal incontinence in the proctological practice. In: Fruehmorgen, P., Bruch, H.-P. (eds.) Non-Neoplastic Diseases of the Anorectum. Kluwer Academic Publishers, Dordrecht (2001)

    Google Scholar 

  28. Hallen L, Johansson C, Laurent C: Cross-linked hyaluronan (Hylan B gel): an injectable remedy for treatment of vocal fold insufficiency—an animal study. Acta Otolaryngol (Stockholm) 119:107, 1999

  29. Hanke, C.W.: Adverse reactions to bovine collagen. In: Klein, A.W. (ed.) Tissue Augmentation in Clinical Practice, pp. 145–154. Procedures and Techniques. Marcel Dekker, New York (1998)

    Google Scholar 

  30. Kazachkov EL, Fridman AB, Friss SA: Granulomatous pleurisy after mammoplasty induced by polyacrylamide gel. (Russian). Arkh Patol 60:58, 1998

  31. Kinney, B.M., Hughes III, C.E.: Soft tissue fillers: An overview. Aesth Surg J 21, 469 (2001)

    CAS  Google Scholar 

  32. Klein, A.W., Elson, M.L.: The history of substances for soft tissue augmentation. Dermatol Surg 26, 1096 (2000)

    CAS  PubMed  Google Scholar 

  33. Kolle FS: Plastic and Cosmetic Surgery. D Appleton, New York, pp 209–230, 1911

  34. Lemperle G, Hoehler H: Granulome nach Unterspritzung von Gesichtsfalten mit Teflon-Paste. In: Hoehler H (Ed.) Plastische und Wiederherstellungschirurgie Schattauer, Stuttgart, pp 335–340, 1975

  35. Lemperle, G., Gauthier-Hazan, N., Lemperle, M.: PMMAmicrospheres (Artecoll) for long-lasting correction ofwrinkles: Refinements and statistical results. Aesth Plast Surg 22, 365 (1998)

    Google Scholar 

  36. Lemperle, G.: Hyaluronsa ure zur Faltenunterspritzung. Arzneimittel-, Therapie-Kritik 3, 635 (2000)

    Google Scholar 

  37. Lemperle, G., Romano, J.J., Busso, M.: Soft tissue augmentation with Artecoll: 10-year history, indications, technique and complications. Dermatol Surg 29, 573 (2003)

    PubMed  Google Scholar 

  38. Lemperle G, Legaz ME (2004) Biocompatibility of injectable microparticles. Aesth Plast Surg, submitted

  39. Lowe, N.J., Maxwell, C.A., Lowe, P.: DuickMG, Shah K: Hyaluronic acid skin fillers: Adverse reactions and skin testing. J Am Acad Dermatol 45, 930 (2001)

    CAS  PubMed  Google Scholar 

  40. Lupton, J.R., Alster, T.S.: Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg 26, 135 (2000)

    CAS  PubMed  Google Scholar 

  41. Manna, F., Dentini, M., Desideri, P., De Pita, O., Mortilla, E., Mars, B.: Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (Hylaform from rooster combs and Restylane from streptococcus) used for soft tissue augmentation. J Eur Acad Dermatol Venerol 13, 183 (1999)

    CAS  Google Scholar 

  42. Mazzoleni F, Dominici C, Lotti T, et al.: Formacryl: Un nuovo biopolimero al servizio della medicina ‘‘piu un endoprotesi che un filler.’’ Dermatologia 1:13, 2000

  43. MisiekDJ, Kent JN, Carr RF: Soft tissue responses to hydroxylapatite particles of different shapes. J Oral Maxillofac Surg 42:150, 1984

  44. Moscona, R.R., Bergman, R., Friedman-Birnbaum, R.: An unusual late reaction to Zyderm I injections: a challenge for treatment. Plast Reconstr Surg 92, 331 (1993)

    CAS  PubMed  Google Scholar 

  45. Morhenn, V.B., Lemperle, G., Gallo, R.L.: Phagocytosis of different particulate dermal filler substances by human macrophages and skin cells. Dermatol Surg 28, 484 (2002)

    PubMed  Google Scholar 

  46. Naoum C, Dasou-Plakida D: Dermal filler materials and botulin toxin. Int J Dermatol 40:606, 200

  47. Narins, R.S., Brandt, F., Leyden, J., Lorenc, Z.P., Rubin, M., Smith, S.: A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 29, 588 (2003)

    PubMed  Google Scholar 

  48. Neto MS, Passy S: Rellenamiento cutaneo y correccion de las deformidades del rostro con el uso de microesferas de PMMA—un nuevo enfoque. In: Proceedings of the 28th Argentinian Congress of Plastic Surgery, Cordoba, pp 1–8, 1999

  49. O’Connor KW, Lehman GA: Endoscopic placement of collagen at the lower esophageal sphincter to inhibit gastroesophageal reflux: a pilot study of 10 medically intractable patients. Gastrointest Endoscop 34:106, 1988

  50. Olenius, M.: The first clinical study using a new biodegradable implant for the treatment of lips, wrinkles and folds. Aesth Plast Surg 22, 97 (1998)

    CAS  Google Scholar 

  51. PannekJ, Brands FH, Schewe J, Senge T: Particle migration following transurethral injection of carbon coated beads for stress urinary incontinence. J Urol 165(Suppl 5):74, 2001

  52. PollackS: Some new injectable dermal filler materials: Hylaform, Restylane, and Artecoll. J Cutan Med Surg 3Suppl 4:S4–S29, 1999

  53. Rapaport, M.J.: VinnikC, Zarem H: Injectable silicone: cause of facial nodules, cellulites, ulceration, and migration. Aesth Plast Surg 20, 267 (1996)

    CAS  Google Scholar 

  54. Requena, C., Izquierdo, M.J., Navarro, M., et al.: Adverse reactions to injectable aesthetic microimplants. Am J Dermatopathol 23, 197 (2000)

    Google Scholar 

  55. Rudolph, C.M., Soyer, H.P., Schuller-Petrovic, S., Kerl, H.: Foreign body granulomas due to injectable aesthetic microimplants. Am J Surg Pathol 23, 113 (1999)

    CAS  PubMed  Google Scholar 

  56. Rubin, J.P.: YaremchukMJ: Complications and toxicities of implantable biomaterials used in facial reconstructive and aesthetic surgery: A comprehensive review of the literature. Plast Reconstr Surg 100, 1 (1997)

    Google Scholar 

  57. Saint-Marc, T., Partisani, M., Poizot-Martin, I., et al.: A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. AIDS 13, 1659 (1999)

    CAS  PubMed  Google Scholar 

  58. Senet, P., Bachelez, H., Ollivaud, L., Vignon-Pennamen, D., Dubertret, L.: Minocycline for the treatment of cutaneous silicone granulomas. Br J Dermatol 140, 985 (1999)

    CAS  PubMed  Google Scholar 

  59. Shafir, R., Amir, A., Gur, E.: Long-term complications of facial injections with Restylane (injectable hyaluronic acid). Plast Reconstr Surg 106, 1215 (2000)

    CAS  PubMed  Google Scholar 

  60. Spenlehauer, G., Vert, M., Benoit, J.P., Boddaert, A.: In vitro and in vivo degradation of poly(D, L-lactide/glycolide) type microspheres made by solvent evaporation method. Biomaterials 10, 557 (1989)

    CAS  PubMed  Google Scholar 

  61. Tomacic-Jeciz, V.J., Merritt, K., Umbreit, T.H.: Significance of type and the size of biomaterial particles on phagocytosis and tissue distribution. J Biomed Mater Res 55, 523 (2001)

    Google Scholar 

  62. Voy E-D, Mohasseb J: Lipoatrophie als seltene Komplikation nach Auffu llung der Nasolabialfalten mit injizierbaren Implantaten. Magazin Aesth Chir 2:, 2002

  63. Whitehead, W.E., Wald, A., Norton, N.J.: Treatment options for fecal incontinence. Dis Colon Rectum 44, 131 (2001)

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Plastic Surgery, University of California, San Diego, CA, USA

    Gottfried Lemperle M.D., Ph.D.

  2. San Diego, CA, USA

    Vera Morhenn M.D.

  3. Frankfurt, Germany

    Ulrich Charrier M.D

Authors
  1. Gottfried Lemperle M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vera Morhenn M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ulrich Charrier M.D
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gottfried Lemperle M.D., Ph.D..

Additional information

This article is being reprinted for ISAPS 50th Anniversary Special Issue.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lemperle, G., Morhenn, V. & Charrier, U. Human Histology and Persistence of Various Injectable Filler Substances for Soft Tissue Augmentation. Aesth Plast Surg 44, 1348–1360 (2020). https://doi.org/10.1007/s00266-020-01827-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00266-020-01827-7

Key words

Search

Navigation